SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/8FF8408D6EACE411DECE9EB6CCBAD79D3AC1B0519E44E31F90AAAA4A33E08DF9C8A48ACA5CD184BDF4A88EFB4B3F55E0>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/8FF8408D6EACE411DECE9EB6CCBAD79D3AC1B0519E44E31F90AAAA4A33E08DF9C8A48ACA5CD184BDF4A88EFB4B3F55E0
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/8FF8408D6EACE411DECE9EB6CCBAD79D3AC1B0519E44E31F90AAAA4A33E08DF9C8A48ACA5CD184BDF4A88EFB4B3F55E0
http://www.w3.org/2000/01/rdf-schema#comment
"This study demonstrated T295A variant to be associated with significantly increased (3/16 patients 17%) inhibitor development."
xsd:string
http://purl.uniprot.org/uniprot/#_705190A5D20AC8E0C47F8DE06A12184A7F852ACC4103149102C13E65E52C4F918EC9801728EC1E5893ACCC8D5027F47C
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/8FF8408D6EACE411DECE9EB6CCBAD79D3AC1B0519E44E31F90AAAA4A33E08DF9C8A48ACA5CD184BDF4A88EFB4B3F55E0
http://purl.uniprot.org/uniprot/A0A224A9M5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8FF8408D6EACE411DECE9EB6CCBAD79D3AC1B0519E44E31F90AAAA4A33E08DF9C8A48ACA5CD184BDF4A88EFB4B3F55E0
http://purl.uniprot.org/uniprot/#_A0A224A9M5-mappedCitation-25382774
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8FF8408D6EACE411DECE9EB6CCBAD79D3AC1B0519E44E31F90AAAA4A33E08DF9C8A48ACA5CD184BDF4A88EFB4B3F55E0